Cargando…
Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FH(Marburg) (FH p.W556R)
OBJECTIVE: Familial hypercholesterolemia (FH) is an autosomal dominant inherited disorder caused by mutations in the low density lipoprotein receptor (LDLR) gene. FH is characterized by elevated plasma LDL cholesterol, premature atherosclerosis, and a high risk of premature myocardial infarction. In...
Autores principales: | Schaefer, Juergen R., Kurt, Bilgen, Sattler, Alexander, Klaus, Günter, Soufi, Muhidien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374117/ https://www.ncbi.nlm.nih.gov/pubmed/22528129 http://dx.doi.org/10.1007/s11789-012-0041-y |
Ejemplares similares
-
Lipoprotein(a)—clinical aspects and future challenges
por: Kurt, Bilgen, et al.
Publicado: (2015) -
Familial Hypercholesterolemia (FH) in Iran: Findings from the Four-Year FH Registry
por: Vaseghi, Golnaz, et al.
Publicado: (2021) -
Cascade Screening for Familial Hypercholesterolemia (FH)
por: Ned, Renée M., et al.
Publicado: (2011) -
The Spectrum of Familial Hypercholesterolemia (FH) in Saudi Arabia: Prime Time for Patient FH Registry
por: Alallaf, Faisal, et al.
Publicado: (2017) -
Fast and Easy Nanopore Sequencing Workflow for Rapid Genetic Testing of Familial Hypercholesterolemia
por: Soufi, Muhidien, et al.
Publicado: (2022)